性结肠炎中的饮食:对其在病变发生和治疗中的作用的叙述性审查
Fares Jamal1, Nour B Odeh2, Mayar Husam Iyad Alatout3
1Division of Hematology and Oncology, Mayo Clinic, Phoenix, USA.
Digestive diseases and sciences
|September 22, 2025
概括
饮食显著影响性结肠炎 (UC) 管理. 健康的脂肪,纤维和地中海饮食可以减轻炎症,而加工食品会使症状恶化. 个性化营养计划是UC患者的关键.
科学领域:
- 胃肠病学和营养科学 胃肠病学和营养科学
- 炎症性肠道疾病研究研究
- 肠道微生物组研究 研究肠道微生物组
背景情况:
- 性结肠炎 (UC) 是一种具有复杂病因的慢性炎症性肠病 (IBD).
- 饮食是影响UC病变和临床过程的关键可修改因素.
- 了解饮食影响对于改善患者的治疗结果至关重要.
研究的目的:
- 审查宏观营养素,食品添加剂和饮食模式对UC的影响.
- 分析饮食如何影响UC病变,症状控制和结果.
- 为UC管理中的饮食干预提供基于证据的建议.
主要方法:
- 关于饮食和UC的科学文献的叙事综述.
- 对调查宏观营养素,食品添加剂和饮食模式的研究进行分析.
- 对各种饮食干预措施的证据评估,包括地中海和低FODMAP饮食.
主要成果:
- 摄入大量的和脂肪,红色/加工肉类和超加工食品加剧了UC,因为它促进了失调和炎症.
- 富含纤维,耐性粉和omega-3脂肪酸的饮食提供保护性的抗炎作用,并支持肠道屏障功能.
- 地中海饮食与UC活性降低和微生物多样性的改善相关;低FODMAP饮食可以缓解症状但不能缓解炎症.
结论:
- 饮食修改,强调全食和特定营养素,可以显著影响UC管理.
- 推个性化,由营养学家主导的营养干预措施,以提高坚持和疾病控制.
- 需要进一步的研究来确定长期的饮食影响,并将营养纳入标准的UC治疗方案.
相关概念视频
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
604
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
604
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
844
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
844
01:29Drugs for Treatment of Ulcerative Colitis in IBD
413
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
413
01:28Peptic Ulcer Disease II: Pathophysiology
1.8K
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
1.8K
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
1.1K
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.1K
01:21Inflammatory Bowel Disease V: Surgical Management
420
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
420